nodes	percent_of_prediction	percent_of_DWPC	metapath
Stanozolol—Danazol—CCL2—Alzheimer's disease	0.0784	0.351	CrCbGaD
Stanozolol—AR—Notch-mediated HES/HEY network—RCAN1—Alzheimer's disease	0.0622	0.0801	CbGpPWpGaD
Stanozolol—Trilostane—ESR1—Alzheimer's disease	0.0585	0.262	CrCbGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—GRN—Alzheimer's disease	0.0425	0.0548	CbGpPWpGaD
Stanozolol—Fluoxymesterone—ESR1—Alzheimer's disease	0.0316	0.141	CrCbGaD
Stanozolol—AR—Nongenotropic Androgen signaling—PLCB1—Alzheimer's disease	0.0303	0.039	CbGpPWpGaD
Stanozolol—Danazol—ESR1—Alzheimer's disease	0.0302	0.135	CrCbGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAQ—Alzheimer's disease	0.0253	0.0326	CbGpPWpGaD
Stanozolol—AR—FOXA1 transcription factor network—SOD1—Alzheimer's disease	0.0198	0.0255	CbGpPWpGaD
Stanozolol—AR—Coregulation of Androgen receptor activity—PTK2B—Alzheimer's disease	0.0197	0.0254	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.018	0.0232	CbGpPWpGaD
Stanozolol—AR—Nongenotropic Androgen signaling—CREB1—Alzheimer's disease	0.0166	0.0214	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—ESR1—Alzheimer's disease	0.0157	0.0202	CbGpPWpGaD
Stanozolol—Progesterone—ESR1—Alzheimer's disease	0.0156	0.0699	CrCbGaD
Stanozolol—AR—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.0153	0.0198	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.0153	0.0198	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.0149	0.0191	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—PPARG—Alzheimer's disease	0.0143	0.0184	CbGpPWpGaD
Stanozolol—AR—FOXA1 transcription factor network—ESR1—Alzheimer's disease	0.0139	0.0179	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.013	0.0168	CbGpPWpGaD
Stanozolol—AR—Notch-mediated HES/HEY network—NOTCH1—Alzheimer's disease	0.0128	0.0164	CbGpPWpGaD
Stanozolol—AR—FOXA1 transcription factor network—INS—Alzheimer's disease	0.0125	0.0161	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—ESR1—Alzheimer's disease	0.0124	0.0159	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.0123	0.0158	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.012	0.0155	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.0113	0.0145	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.011	0.0142	CbGpPWpGaD
Stanozolol—AR—Regulation of Androgen receptor activity—GSK3B—Alzheimer's disease	0.0109	0.014	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.0106	0.0136	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.0104	0.0134	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.01	0.0129	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.00988	0.0127	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.00965	0.0124	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.00936	0.0121	CbGpPWpGaD
Stanozolol—Progesterone—CYP2D6—Alzheimer's disease	0.0093	0.0416	CrCbGaD
Stanozolol—AR—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.00929	0.012	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—GSK3A—Alzheimer's disease	0.0092	0.0118	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.00904	0.0116	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.00904	0.0116	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.00876	0.0113	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.0086	0.0111	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.00855	0.011	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—CAV1—Alzheimer's disease	0.00823	0.0106	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.00769	0.00991	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.00762	0.00982	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.00749	0.00965	CbGpPWpGaD
Stanozolol—AR—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	0.00735	0.00946	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—GSK3B—Alzheimer's disease	0.00719	0.00926	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—CREB1—Alzheimer's disease	0.00713	0.00919	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.00695	0.00895	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.00675	0.00869	CbGpPWpGaD
Stanozolol—AR—Nongenotropic Androgen signaling—AKT1—Alzheimer's disease	0.00665	0.00856	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.00648	0.00834	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	0.00644	0.0083	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.00627	0.00807	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.00599	0.00771	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.00574	0.00739	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.0057	0.00734	CbGpPWpGaD
Stanozolol—AR—Gene Expression—PHF1—Alzheimer's disease	0.00543	0.007	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.00534	0.00688	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	0.00519	0.00669	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	0.00467	0.00602	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.00455	0.00586	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.0043	0.00554	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	0.00392	0.00505	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.00387	0.00499	CbGpPWpGaD
Stanozolol—AR—Coregulation of Androgen receptor activity—AKT1—Alzheimer's disease	0.00387	0.00498	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	0.00372	0.0048	CbGpPWpGaD
Stanozolol—AR—Gene Expression—TFAM—Alzheimer's disease	0.0035	0.00451	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	0.00346	0.00446	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.00338	0.00435	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.00337	0.00434	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	0.00325	0.00419	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	0.00309	0.00398	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	0.00308	0.00397	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	0.00294	0.00378	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	0.00287	0.00369	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.00286	0.00368	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—AKT1—Alzheimer's disease	0.00286	0.00368	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	0.00264	0.00339	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.00245	0.00316	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	0.00243	0.00313	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	0.00223	0.00288	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	0.00222	0.00286	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.00214	0.00275	CbGpPWpGaD
Stanozolol—AR—Gene Expression—EIF2S1—Alzheimer's disease	0.00211	0.00271	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	0.00209	0.00269	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.00207	0.00266	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.00198	0.00255	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.00195	0.00251	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	0.00187	0.00241	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	0.00184	0.00237	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	0.00155	0.002	CbGpPWpGaD
Stanozolol—AR—Gene Expression—ESR1—Alzheimer's disease	0.00103	0.00133	CbGpPWpGaD
Stanozolol—AR—Gene Expression—NOTCH1—Alzheimer's disease	0.000995	0.00128	CbGpPWpGaD
Stanozolol—AR—Gene Expression—PPARG—Alzheimer's disease	0.000939	0.00121	CbGpPWpGaD
Stanozolol—AR—Gene Expression—AKT1—Alzheimer's disease	0.000371	0.000478	CbGpPWpGaD
